Rigel: Q3 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported a loss of $5.7 million in its third quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 3 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 7 cents per share.
The drug developer posted revenue of $28.1 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $27.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL
